°¾ÀYµhªºÃĪ«ªvÀø

¡¶ºC©Ê°¾ÀYµh¥²¶·¸g¥Ñ¯«¸g¬ìÂå®v¶EÂ_¡Aµo§@¤Ñ¼Æ¤@­Ó¤ë»Ý¶W¹L15¤Ñ¥H¤W¡C

ºC©Ê°¾ÀYµh (chronic migraine) ¬OÅãµÛ¼vÅT¥Í¬¡«~½èªº¯«¸g¯e¯f¡Aªø´ÁªºÀYµh¡Bµo§@®É¶¡¤]ªø¡A¹w¥ü (aura) ±a¨Óªº¤£¾A»Pµh­W¡A¯uªº¬OÅý¤H¯kµhÃø­@¡C

­nªvÀø«æ©Êµo§@¡A¥Ø«e³Q»{¬°³Ì¦³®ÄªºÃÄ«~¬OÈÐTriptanÃþÃÄ«~ÈСA¥L¬O¤@ºØ5-HT¨üÅé§@¥Î¾¯¡A§@¥Î¦b5-HT1B¡B1D¨üÅé¡C

§@¥Î¦b1B¨üÅé¡A¥i¥H¦¬ÁY¦åºÞ (vasoconstriction)¡A­°§C¦åÄé¬y¶q¡C

§@¥Î¦b1D¨üÅé¡A¥i¥H´î¤Ö³\¦h»P¯kµh¬ÛÃöªº´C¤¶ª«ÄÀ©ñ¡A¨Ò¦p¦åºÞ¬¡©ÊÐ`–¦ (vasoactive peptide)¡C

ÈЦҬìÂŨt²Î©Êºî½×¡GTriptansÃþÃÄ«~Àø®Ä¶È¦³¨Ç·L®t²§ÈÐ

®Ú¾Ú¤@¶µ¦Ò¬ìÂŨt²Î©Êºî½×¡A¤ñ¸û¤£¦PTriptansÃþÃÄ«~²×¤î«æ©Ê°¾ÀYµhªº®ÄªG¡A¥HªAÃÄ«á2¤p®É¯kµh½w¸Ñªº»Ýªv¤H¼Æ (number needed to treat, NNT) ªí²{¡C

¡¶TriptanÃþÃÄ«~ªº¶¡±µ¤ñ¸û®ÄªG®t²§¨Ã¤£¤j¡C

§Ú­Ì³o¸Ì¾ã²z±`¥Îªº¤TºØ³t®Ä«¬TriptanÃþÃÄ«~¡A¤fªA°_©l§@¥Î®É¶¡¬ù¥b¤p®É¡A¦ý¦pªG¬O¯S®í¾¯«¬¡A¨Ò¦p»óµÄ§l¤J¡B¤f·»±Y´²¿õ¡A®ÄªG·|§ó§Ö¡A¥HSumatriptan»óµÄ§l¤J¨Ó»¡¡A¥u­n15¤ÀÄÁ¡C

TriptanÃÄ«~ªº¸nªù¦b©óÈЦåºÞ¦¬ÁYÈСA¦]¦¹¡A¤@¯ë¤£«ØÄ³¨Ï¥Î©óÈЦåºÞ¤£¦nªº¯f¤HÈСA¥]¬A«aª¬°Ê¯ß¦åºÞ¯e¯f¡B¸£¦åºÞ¯e¯f»P¶gÃä¦åºÞ¯e¯f¡C

»Ý¯S§Oª`·NªºÃÄ«~¥æ¤¬§@¥Î¬OÈгÁ¨¤ÆPÃþÃÄ«~ÈШҦpergotamine¡A¨Ï¥ÎTriptanÃþÃÄ«~24¤p®É¤º¡A¤£¥i¥H¨Ï¥Î³Á¨¤ÆPÃþÃÄ«~¡C